SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-14-065966
Filing Date
2014-09-12
Accepted
2014-09-12 06:45:42
Documents
2
Period of Report
2014-09-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a14-20796_18k.htm 8-K 23706
2 EX-99.1 a14-20796_1ex99d1.htm EX-99.1 77597
  Complete submission text file 0001104659-14-065966.txt   102408
Mailing Address 1 LANDMARK SQUARE, SUITE 1122 STAMFORD CT 06901
Business Address 1 LANDMARK SQUARE, SUITE 1122 STAMFORD CT 06901 203-658-4749
Loxo Oncology, Inc. (Filer) CIK: 0001581720 (see all company filings)

IRS No.: 462996673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36562 | Film No.: 141099497
SIC: 2834 Pharmaceutical Preparations